Nachrichten zur Helius Medical Technologies Inc. Aktie

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference…

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

NEWTOWN, Pa., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

…

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Company to host call at 4:30pm today Company to host call at 4:30pm today…

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple…

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

…

Ausblick: Helius Medical Technologies A informiert über die jüngsten Quartalsergebnisse

Helius Medical Technologies A öffnet am 13.05.2024 die Bücher zum am 31.03.2024 abgelaufenen Quartal.1 Analyst schätzt, dass Helius Medical …

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”),…

Helius Medical Technologies raises $6.4M via equity offering

…

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…

Earnings call: Helius Medical Technologies outlines reimbursement strategy By Investing.com

Earnings call: Helius Medical Technologies outlines reimbursement strategy…

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

…

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius…

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

-- Brooks Rehabilitation Hospital adds a second site to the registrational program in stroke, and brings the total number of…

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

…

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

-- Collaborative project between Pacific Blue Cross and HealthTech Connex designed to reduce long-term disability and improve quality of life…

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

-- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales…

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

-- PoNS® devices to be provided to a least five sites in five separate administrative regions within Québec ---- Government-funded…

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

NEWTOWN, Pa., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

-- UPC numbers assigned by Wolters Kluwer Health, provider of trusted clinical technology ---- PoNS system and mouthpiece will be…

Helius Medical Technologies: Startek Rückzug von Leerverkäufer Walleye Capital - Aktiennews

Newtown, PA (www.aktiencheck.de) - Leerverkäufer Walleye Capital LLC hat Netto-Leerverkaufsposition in Aktien von Helius Medical Technologies stark reduziert: Die Shortseller von…

Helius Medical Technologies: Starker Rückzug von Leerverkäufer Walleye Capital - Aktiennews

Newtown, PA (www.aktiencheck.de) - Leerverkäufer Walleye Capital LLC hat Netto-Leerverkaufsposition in Aktien von Helius Medical Technologies stark reduziert: Die Shortseller von…

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science…

Helius Medical Technologies: Walleye Capital schaltet auf Short-Attacke um - Aktiennews

Newtown, PA (www.aktiencheck.de) - Leerverkäufer Walleye Capital LLC hebt Netto-Leerverkaufsposition in Aktien von Helius Medical Technologies deutlich an: Die Shortseller von…

Helius Medical Technologies: Walleye Capital reduziert Leerverkauf-Aktivitäten massiv - Aktiennews

Newtown (www.aktiencheck.de) - Leerverkäufer Walleye Capital LLC senkt Netto-Leerverkaufsposition in Aktien von Helius Medical Technologies massiv: Die Shortseller von Walleye Capital…

XFRA : Deletion of Instruments from Boerse Frankfurt - 17.08.2023

The following instruments on Boerse Frankfurt do have their last trading day on 17.08.2023 Die folgenden Instrumente in Boerse Frankfurt haben…

XFRA : ISIN Change

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA13509T1057 MTL Cannabis Corp. 17.08.2023 CA5539261068 MTL Cannabis Corp. 18.08.2023 Tausch 1:1 US42328V6039 Helius Medical Technologies Inc. 17.08.2023 US42328V8019 Helius Medical Technologies Inc. 18.08.2023 Tausch 50:1 US00972G1085 Akari Therapeutics PLC 17.08.2023 US00972G2075 Akari Therapeutics PLC 18.08.2023 Tausch…

XFRA : Korrektur: 26HA: HEUTE EX Corporate Action / EX Corporate Action TODAY

Folgendes Instrument wird heute EX Corporate Action gehandelt. Aus technischen Gruenden wird der EX-Indikator heute nicht angezeigt. Es wurden keine…

XFRA : INSTRUMENT_SUSPENSION - US42328V6039

Instrument ID [5946688] (26HA - US42328V6039) suspended...…

XFRA : 26HA: HEUTE EX Corporate Action / EX Corporate Action TODAY

Folgendes Instrument wird heute nicht EX Corporate Action gehandelt. Aus technischen Gruenden wird der EX-Indikator heute angezeigt. Es wurden keine…

XFRA : 26HA: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

Helius Medical Technologies Announces Reverse Stock Split

NEWTOWN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…

Form 8-K HELIUS MEDICAL TECHNOLOG For: Aug 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates

Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of 45.45% and 50.59%, respectively, for the quarter ended June…

Form 10-Q HELIUS MEDICAL TECHNOLOG For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program

Sixth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects adherence…

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina

-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve…

Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest

NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…

Helius Medical Technologies to Present at LD Micro Invitational XIII 2023

Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech…

Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day

NEWTOWN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (Nasdaq:HSDT), a neurotech company focused on delivering…

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…

Form 10-Q HELIUS MEDICAL TECHNOLOG For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- Helius…

Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

MS, Stroke and mmTBI Cover Broader Set of Indications Across North American Markets MS, Stroke and mmTBI Cover Broader Set…

Form 8-K HELIUS MEDICAL TECHNOLOG For: Mar 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary

NEWTOWN, Pa., March 23, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…

Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device

-- Agreement extends existing partnership ---- Collaboration makes HealthTech Connex the exclusive provider of PoNS Therapy in the Vancouver area…

dpa-AFX ProFeed